The long‐term inhibition of EZH2 does not appear to be beneficial in adolescent or young adult osteoporosis mice model; short‐term or local applications using EZH2 inhibitor in mature or engineered skeletal tissue may accelerate the maturation of differentiated osteoblasts. The gene discussed is EZH2; the disease is osteoporosis.